Impaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme

British Journal of Pharmacology

Volumn 172, Issue 19, 2015, Pages 4603-4614

  Avraham, H K ^a,b   Jiang, S ^a   Fu, Y ^a   Rockenstein, E ^c   Makriyannis, A ^b   Wood, J ^b   Wang, L ^a   Masliah, E ^c   Avraham, S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; CYCLOOXYGENASE 2; DOUBLECORTIN; ENDOCANNABINOID; FATTY ACID AMIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN GP 120; PROSTAGLANDIN E2; AMIDASE; FATTY-ACID AMIDE HYDROLASE; GLIAL FIBRILLARY ASTROCYTIC PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN LEVEL; CELL COUNT; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; ENDOCANNABINOID BRAIN LEVEL; FAAH GENE; GENE DELETION; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; MOUSE; NERVE CELL NECROSIS; NERVE CELL STIMULATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL NICHE; TRANSGENIC MOUSE; ANIMAL; BRAIN; GENETICS; METABOLISM; PHYSIOLOGY;

AMIDOHYDROLASES; ANIMALS; BRAIN; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOCANNABINOIDS; GENE DELETION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIV ENVELOPE PROTEIN GP120; MICE, TRANSGENIC; NEUROGENESIS;

EID: 84940955701     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12657     Document Type: Article

References (65)

1. Abrous DN, Koehl M, Le Moal M, (2005). Adult neurogenesis: from precursors to network and physiology. Physiol Rev 85: 523-569.
2. Aguado T, Monory K, Palazuelos J, Stella N, Cravatt B, Lutz B, et al. (2005). The endocannabinoid system drives neural progenitor proliferation. FASEB J 19: 1704-1706.
3. Aguado T, Palazuelos J, Monory K, Stella N, Cravatt B, Lutz B, et al. (2006). The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J Neurosci 26: 1551-1561.
4. Aguado T, Romero E, Monory K, Palazuelos J, Sendtner M, Marsicano G, et al. (2007). The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J Biol Chem 282: 23892-23898.
5. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013). The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
6. Bardou I, DiPatrizio N, Brothers HM, Kaercher RM, Baranger K, Mitchem M, et al. (2012). Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging. Health 4 (9A): 679-684.
7. Bari M, Rapino C, Mozetic P, Maccarrone M, (2010). The endocannabinoid system in gp120-mediated insults and HIV-associated dementia. Exp Neurol 224: 74-84.
8. Bath KG, Akins MR, Lee FS, (2012). BDNF control of adult SVZ neurogenesis. Dev Psychobiol 54: 578-589.
9. Clement AB, Hawkins EG, Lichtman AH, Cravatt BF, (2003). Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J Neurosci 23: 3916-3923.
10. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, et al. (2001). Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98: 9371-9376.
11. Cruz Duarte P, St-Jacques B, Ma W, (2012). Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model. Exp Neurol 234: 466-481.
12. De Lago E, Gõmez-Ruiz M, Moreno-Martet M, Fernández-Ruiz J, (2009). Cannabinoids, multiple sclerosis and neuroprotection. Expert Rev Clin Pharmacol 2: 645-660.
13. D'hooge R, Franck F, Mucke L, De Deyn PP, (1999). Age-related behavioural deficits in transgenic mice expressing the HIV-1 coat protein gp120. Eur J Neurosci 11: 4398-4402.
14. Ellis R, Langford D, Masliah E, (2007). HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8: 33-44.
15. Fauci AS, (1988). The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617-622.
16. Fernández-Ruiz J, (2012). Cannabinoid drugs for neurological diseases: what is behind? Rev Neurol 54: 613-628.
17. Fernández-Ruiz J, Pazos MR, Garciá-Arencibia M, Sagredo O, Ramos JA, (2008). Role of CB2 receptors in neuroprotective effects of cannabinoids. Mol Cell Endocrinol 286: S91-S96.
18. Fernández-Ruiz J, García C, Sagredo O, Gõmez-Ruiz M, de Lago E, (2010a). The endocannabinoid system as a target for the treatment of neuronal damage. Expert Opin Ther Targets 14: 387-404.
19. Fernández-Ruiz J, Hernández M, Ramos JA, (2010b). Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther 16: e72-e91.
20. Fernández-Ruiz J, Moreno-Martet M, Rodríguez-Cueto C, Palomo-Garo C, Gõmez-Cañas M, Valdeolivas S, et al. (2011). Prospects for cannabinoid therapies in basal ganglia disorders. Br J Pharmacol 163: 1365-1378.
21. Goncalves MB, Suetterlin P, Yip P, Molina-Holgado F, Walker DJ, Oudin MJ, et al. (2008). A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. Mol Cell Neurosci 38: 526-536.
22. Goncalves MB, Williams EJ, Yip P, Yáñez-Muñoz RJ, Williams G, Doherty P, (2010). The COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain. Br J Pharmacol 159: 1118-1125.
23. Han J, Kesner P, Metna-Laurent M, Duan T, Xu L, Georges F, et al. (2012). Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 148: 1039-1050.
24. Harkany T, Guzman M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K, (2007). The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 28: 83-92.
25. Junier MP, (2000). What role(s) for TGFalpha in the central nervous system? Prog Neurobiol 62: 443-473.
26. Kamiguchi H, Yoshida K, Wakamoto H, Inaba M, Sasaki H, Otani M, et al. (1996). Cytokine-induced selective increase of high-molecular-weight bFGF isoforms and their subcellular kinetics in cultured rat hippocampal astrocytes. Neurochem Res 21: 701-706.
27. Karanian DA, Karim SL, Wood JT, Williams JS, Lin S, Makriyannis A, et al. (2007). Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage. J Pharmacol Exp Ther 322: 1059-1066.
28. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
29. Krathwohl MD, Kaiser JL, (2004). HIV-1 promotes quiescence in human neural progenitor cells. J Infect Dis 190: 216-226.
30. Krucker T, Toggas SM, Mucke L, Siggins GR, (1998). Transgenic mice with cerebral expression of human immunodeficiency virus type-1 coat protein gp120 show divergent changes in short- and long-term potentiation in CA1 hippocampus. Neuroscience 83: 691-700.
31. Laming PR, Kimelberg H, Robinson S, Salm A, Hawrylak N, Müller C, et al. (2000). Neuronal-glial interactions and behaviour. Neurosci Biobehav Rev 24: 295-340.
32. Lawrence DM, Durham LC, Schwartz L, Seth P, Maric D, Major EO, (2004). Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J Virol 78: 7319-7328.
33. Lu TS, Avraham HK, Seng S, Tachado SD, Makriyannis A, Avraham S, (2008). Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvasculature endothelial cells. J Immunol 181: 6406-6416.
34. Maccorone M, Piccirill S, Battista N, Del Duca C, Nappi G, Corasaniti TM, et al. (2004). Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex. J Neurochem 89: 1293-1300.
35. Maekawa M, Takashima N, Matsumata M, Ikegami S, Kontani M, Hara Y, et al. (2009). Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PLoS ONE 4: e5085.
36. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA, (1992). Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 32: 321-329.
37. Masliah E, Rockenstein E, Mante M, Crews L, Spencer B, Adame A, et al. (2011). Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. PLoS ONE 6: e19338.
38. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
39. Molina-Holgado F, Rubio-Araiz A, García-Ovejero D, Williams RJ, Moore JD, Arévalo-Martín A, et al. (2006). CB2 cannabinoid receptors promote mouse neural stem cell proliferation. Eur J Neurosci 25: 629-634.
40. Muboh MK, Johson HF, Farenkia GN, (2006). HIV-1 infection of human brain-derived neural progenitor cells. Retrovirology 3: 43.
41. Mucke L, Abraham CR, Ruppe MD, Rockenstein EM, Toggas SM, Mallory M, (1995). Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein. J Exp Med 181: 1551-1556.
42. Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, et al. (1999). Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19: 2987-2995.
43. Okamoto S, Kang YJ, Brechtel CW, Siviglia E, Russo R, Clemente A, et al. (2007). HIV/gp120 decreases adult neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal and G1 arrest. Cell Stem Cell 1: 230-236.
44. Panikashvili D, Shein NA, Mechoulam R, Thembovler V, Kohen R, Alexandrovich A, et al. (2006). The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 22: 257-264.
45. Peng D, Hu TL, Jiang A, Washington MK, Moskaluk CA, Schneider-Stock R, et al. (2001). Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas. PLoS ONE 6: e22009.
46. Portegies P, Brew BJ, (1991). Update on HIV-related neurological illness. AIDS 5 (Suppl. 2): S211-S217.
47. Ramírez BG, Blázquez C, Gõmez del Pulgar T, Guzmán M, de Ceballos ML, (2005). Prevention of Alzheimer's disease by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25: 1904-1913.
48. Rockenstein E, Mante M, Adame A, Crews L, Moessler H, Masliah E, (2007). Effects of cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease. Acta Neuropathol 113: 265-275.
49. Rueda D, Navarro B, Martinez-Serrano A, Guzman M, Galve-Roperh I, (2002). The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. J Biol Chem 277: 46645-46650.
50. Sagredo O, Pazos MR, Satta V, Ramos JA, Pertwee RG, Fernández-Ruiz J, (2011). Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease. J Neurosci Res 89: 1509-1518.
51. Scemes E, (2000). Components of astrocytic intercellular calcium signaling. Mol Neurobiol 22: 167-179.
52. Schwartz L, Major EO, (2006). Neural progenitors and HIV-1-associated central nervous system disease in adults and children. Curr HIV Res 4: 319-327.
53. Schwartz L, Civitello L, Dunn-Pirio A, Ryschkewitsch S, Berry E, Cavert W, et al. (2007). Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue. J Neurovirol 13: 274-283.
54. Seri B, Alvarez-Buylla A, (2002). Neural stem cells and the regulation of neurogenesis in the adult hippocampus. Clin Neurosci Res 2: 11-16.
55. Solbrig MV, Hermanowicz N, (2008). Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats. J Neurovirol 14: 252-260.
56. Spranger M, Lindholm D, Bandtlow C, Heumann R, Gnahn H, Näher-Noé M, et al. (1990). Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur J Neurosci 2: 69-76.
57. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L, (1994). Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188-193.
58. Toggas SM, Masliah E, Mucke L, (1996). Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 706: 303-307.
59. Tran PB, Miller RJ, (2005). HIV-1, chemokines and neurogenesis. Neurotox Res 8: 149-158.
60. Vardeh D, Wang D, Costigan M, Lazarus M, Saper CB, Woolf CJ, et al. (2009). COX-2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice. J Clin Invest 119: 287-294.
61. Vinod KY, Xie S, Psychoyos D, Hungund BL, Cooper TB, Tejani-Butt SM, (2012). Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats. PLoS ONE 7: e36743.
62. Williams J, Wood J, Pandarinathan L, Karanian DA, Bahr BA, Vouros P, et al. (2007). Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Anal Chem 79: 5582-5593.
63. Winner B, Rockenstein E, Lie DC, Aigner R, Mante M, Bogdahn U, et al. (2007). Mutant alpha-synuclein esacerbates age-related decrease of neurogenesis. Neurobiol Aging 29: 913-925.
64. Woodward DF, Liang Y, Krauss AH-P, (2008). Prostamides (prostaglandin-ethanolamides) and their pharmacology. Br J Pharmacol 153: 410-419.
65. Yoshida K, Kakihana M, Chen LS, Ong M, Baird A, Gage FH, (1992). Cytokine regulation of nerve growth factor-mediated cholinergic neurotrophic activity synthesized by astrocytes and fibroblasts. J Neurochem 59: 919-931.